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        Introduction 
  In response to different assaults, cells initially activate survival 
pathways that prevent protein damage and facilitate recovery. 
If the stress is unsustainable, cell death is induced ( Beere, 2004 ). 
Apoptosis, a major form of cell death, eliminates damaged cells 
when triggered by external and physiological stimuli. The main 
effectors of apoptosis are a set of proteases called caspases (cys-
teinyl and aspartate-specifi  c proteases;   Beere, 2004  ). Initiator 
caspases (2, 8, 9, and 10) are activated by upstream events and 
stimulate the activity of executioner caspases (3, 6, and 7), which 
promote apoptosis through the cleavage of protein substrates 
(  Green, 2005  ). Although a study has suggested that caspase-3 
and -7 show a high degree of homology and have redundant ac-
tivities (  Kuribayashi et al., 2006  ), recent in vivo experiments 
demonstrated that both are independently required for mito-
chondria-mediated apoptosis (  Lakhani et al., 2006  ). The activa-
tion of caspase-9 occurs by a conformational change within a 
macromolecular complex that is assembled by a scaffolding 
molecule, Apaf-1, in response to a specifi  c ligand, cytochrome   c  
(cyt   c  ;   Zou et al., 1997  ). Cyt   c   induces the heptamerization of 
Apaf-1 followed by the recruitment of procaspase-9. This com-
plex is known as the apoptosome and promotes the activation of 
procaspase-9, which processes caspase-3 and -7 to induce pro-
tein catabolism and apoptosis. 
  It is well established that the expression of several pro- 
and antiapoptotic proteins is in part regulated posttranscription-
ally (  Dimri et al., 1995  ;   Lowe and Lin, 2000  ;   Ikeguchi et al., 
2002  ;   Wang et al., 2003  ). Indeed, in response to some stresses, 
elevated protein levels of p21 
Waf1  , p53, and bcl-2 are observed, 
which cannot entirely be explained by an increase in their rate of 
transcription (  Roninson, 2002  ;   Yamasaki, 2003  ). Recent obser-
vations implicate the RNA-binding protein HuR in stress-
induced apoptosis. For example, UV light treatment induces the 
stability of p21 
Waf1   mRNA as well as the translation of p53 and 
the antiapoptotic factor prothymosin      (proT  )  by  stimulating 
the association of HuR with these messages (  Wang et al., 2000; 
T
he RNA-binding protein HuR affects cell fate by 
regulating the stability and/or the translation of 
messenger RNAs that encode cell stress response 
proteins. In this study, we delineate a novel regulatory 
mechanism by which HuR contributes to stress-induced 
cell death. Upon lethal stress, HuR translocates into the cyto-
plasm by a mechanism involving its association with the 
apoptosome activator pp32/PHAP-I. Depleting the expres-
sion of pp32/PHAP-I by RNA interference reduces both 
HuR cytoplasmic accumulation and the efﬁ  ciency of cas-
pase activation. In the cytoplasm, HuR undergoes caspase-
mediated cleavage at aspartate 226. This cleavage activity 
is signiﬁ  cantly reduced in the absence of pp32/PHAP-I. 
Substituting aspartate 226 with an alanine creates a 
noncleavable isoform of HuR that, when over  expressed, 
maintains its association with pp32/PHAP-I and delays the 
apoptotic response. Thus, we propose a model in which HuR 
association with pp32/PHAP-I and its   caspase-mediated 
cleavage constitutes a regulatory step that contributes to 
an ampliﬁ  ed apoptotic response.
  Caspase-mediated cleavage of HuR in the 
cytoplasm contributes to pp32/PHAP-I regulation of 
apoptosis 
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  Figure 1.       HuR protein promotes cell death upon lethal stress.   (A) Knockdown of HuR expression by RNAi in HeLa cells. HeLa cells were transfected with 
RNAi duplexes against HuR mRNA (siRNA-HuR) or control (siRNA-C) and harvested every 24 h for 96 h. Western blot analyses were performed using 3   μ  g 
of total cell extract. The blot was probed with antibodies against HuR and G3BP (loading control). (B) AP  –  HuR-GST rescues the normal levels of cell death 
upon STS treatment. (top) Schematic representation of the constructs used to rescue siRNA-treated cells. HuR-GST and GST alone were conjugated to AP 
(antennapedia) peptide. (bottom) HeLa cells depleted (panels b  –  d) or not depleted (panel a) of HuR were incubated for 5 h with 1     M STS. 16 h before 
stress, the cells were also incubated with 50 nM AP  –  HuR-GST (panel d) or AP-GST (panel c). The percentage of dead cells was quantiﬁ  ed by subtracting the 115 THE ROLE OF H  U  R CLEAVAGE IN APOPTOSIS   •   MAZROUI ET AL.
Mazan-Mamczarz et al., 2003  ;   Lal et al., 2005  ). HuR is a well-
characterized, ubiquitously expressed posttranscriptional regula-
tor belonging to the embryonic lethal abnormal vision phenotype/
Hu family (in fl  ies;   Robinow et al., 1988  ). HuR has three highly 
conserved motifs belonging to the RNA recognition motif (RRM) 
superfamily and a hinge region between RRMs 2 and 3 named 
the HuR nucleocytoplasmic shuttling (HNS) domain (  Brennan 
and Steitz, 2001  ). It has been shown that the HNS domain regu-
lates the localization of HuR by mediating its association with 
adaptor proteins for nuclear export such as pp32/PHAP-I and 
APRIL (  Brennan et al., 2000  ;   Fan et al., 2003b  ;   Jiang et al., 
2003  ) and with import factors transportin-1, -2, and importin     
(  Rebane et al., 2004  ;   Wang et al., 2004;     van der Giessen and 
Gallouzi, 2007  ). Under normal conditions, transportin-2 regulates 
the nuclear import of HuR, whereas pp32/PHAP-I and APRIL 
are involved in its export (  Gallouzi and Steitz, 2001  ;   Rebane 
et al., 2004  ). Recently, it has been demonstrated that pp32/
PHAP-I and SET     are implicated in both caspase-dependent and 
-independent cell death. SET     appears to have an antiapoptotic 
role in blocking caspase-independent cell death (  Fan et al., 2003a  ), 
whereas pp32/PHAP-I acts as a proapoptotic factor by stimulat-
ing the activity of the apoptosome complex (  Jiang et al., 2003  ). 
SET     and pp32/PHAP-I contain highly acidic domains through 
which they associate with the HNS-RRM3 motifs of the HuR 
protein (  Brennan et al., 2000  ). This observation and the fact that, 
like HuR, pp32/PHAP-I shuttles between the nucleus and the 
cytoplasm (  Brennan et al., 2000  ) raise the possibility that HuR 
also regulates pro- or antiapoptotic signaling pathways through 
protein – protein  interactions.  Although  different  stresses  trigger 
the accumulation of HuR in the cytoplasm via a mechanism in-
volving both pp32/PHAP-I and APRIL (  Gallouzi et al., 2001  ; 
  Higashino et al., 2005  ), the functional relevance of HuR associa-
tion with its protein ligands in deciding cell fate is still elusive. 
  It has been observed that despite their ability to induce cell 
death, stresses like UV, proteasome inhibition, and amino acid 
starvation do not signifi  cantly affect the expression of HuR. 
Rather, they induce its partial cytoplasmic accumulation (  Wang 
et al., 2000; Mazan-Mamczarz et al., 2003  ;   Lal et al., 2005  ; 
  Mazroui et al., 2007  ). Therefore, the role of HuR in cell death may 
be the result of changes in its cellular localization, which is medi-
ated by protein partners. In this study, we address this, showing that 
HuR enhances caspase-mediated apoptosis by a novel regulatory 
mechanism by presenting evidence that links HuR cleavage via a 
specifi  c caspase to amplifi  cation of the apoptotic response. 
  Results 
  RNAi-mediated HuR depletion delays 
staurosporine-induced cell death 
  To investigate the role of HuR in stress response, we depleted its 
expression in HeLa cells using RNAi. Subsequently, these cells 
were treated with lethal doses of several stresses such as heat 
shock (HS; Fig. S1, available at http://www.jcb.org/cgi/content/
full/jcb.200709030/DC1;   Gallouzi et al., 2000  ), staurosporine 
(STS; a potent apoptotic inducer;   Fig. 1;     Desagher et al., 1999  ), 
or proteasome inhibitor (MG132; Fig. S3;   Mazroui et al., 2007  ). 
The siRNA duplex against HuR message (siRNA-HuR;   van der 
Giessen et al., 2003  ) but not the control siRNA (siRNA-C) effi  -
ciently depleted HuR protein levels (  >  85%;   Fig. 1 A  ). The per-
centage of death induced by 1     M STS for 5 h was signifi  cantly 
lower (15%) in siRNA-HuR  –  treated cells compared with cells 
treated with siRNA-C (89%;   Fig. 1 B  ). To test whether the de-
crease of cell death in HuR-depleted cells was associated with a 
reduction in apoptosis, we quantifi  ed the percentage of annexin 
V/propidium iodide (PI)  –  positive cells using fl  ow cytometry 
(  Martin et al., 1995  ). Annexin V binds to externalized phosphat-
idylserines at the surface of apoptotic cells. As shown in   Fig. 1 C  , 
the depletion of HuR resulted in a signifi  cant decrease in the 
number of annexin V  –  positive cells (from 44.9 to 17.3%;   Fig. 1 C  , 
compare siRNA-Ctr and siRNA-HuR dot plots and bar graph). 
The reduced levels of STS-mediated apoptosis were confi  rmed 
by the signifi  cant reduction in the number of condensed and 
fragmented nuclei in STS-treated HeLa cells depleted of HuR 
(7.5%) compared with the mock-depleted cells (71.6%;  Fig. 1 D ). 
Similar results were obtained with other stresses such as HS 
(Fig. S1) or MG132 (Fig. S3). Upon prolonged treatments with 
either 1     M STS (  >  10 h), HS (  >  3 h at 45  °  C), or 10    M  MG132 
(  >  36 h), HuR-depleted cells undergo death (unpublished data); 
thus, we concluded that depleting HuR signifi  cantly delays but 
does not prevent apoptosis. 
  To ensure that the observed delay in apoptosis was a direct 
consequence of the depletion of HuR, we performed rescue 
experiments using the cell-permeable peptide AP conjugated 
to either HuR-GST or to GST alone (Fig. S1 B;   Gallouzi and 
Steitz, 2001  ). HuR knockdown cells were effi  ciently rescued 
from STS-induced cell death (  >  90%) with the addition of 
50 nM AP  –  HuR-GST but not AP-GST (  Fig. 1 B,   b  –  d). In these 
experiments, 50 nM AP-conjugated proteins was not toxic to 
cells growing under normal conditions (Fig. S2 A, available at 
number of adherent cells that remained upon STS treatment from the total number of cells before stress. Representative phase-contrast ﬁ  elds are shown. 
For each panel, ﬁ  ve randomly chosen ﬁ  elds of 300 cells were counted before and after STS treatment. Values are   ±  SEM from ﬁ  ve independent experiments. 
(C) HeLa cells treated with siRNA as described in A in the presence of 1     M STS for 3 h were analyzed by staining with annexin V  –  FITC and PI and by ﬂ  ow 
cytometry. The percentage of apoptotic cells (right boxes) upon STS treatment was determined for HuR (siRNA-HuR) or control siRNA (siRNA-Ctr)-treated 
HeLa cells. The values were normalized to control untreated cells. (D, top) HeLa cells depleted of HuR were treated with 1     M STS for 3 h. Cells were ﬁ  xed, 
and nuclei were stained with DAPI to view the presence of condensed and fragmented nuclei. (bottom) The graph represents the number of apoptotic cells 
after treatment as described in E. For each bar, ﬁ  ve randomly chosen ﬁ  elds of 300 nuclei were counted before and after STS treatment. The arrowheads 
point to apoptotic cells. (C and D) Values are the means   ±   SEM (error bars) from three independent experiments. (E) The cleavage of caspase-3 upon STS 
treatment is signiﬁ  cantly reduced in the absence of HuR. siRNA-HuR  –   and C  –  treated cells 3 d after transfection were treated with 1     M STS for 3 h. 25   μ  g 
of total cell extract was used for Western blotting, and the membrane was probed for caspase-3 and G3BP. The molecular mass of the caspase-3 CP 
(caspase-3  –  CP) is     17 kD, whereas the precursor is 35 kD. (F) STS-induced PARP cleavage depends on HuR protein. HeLa cells depleted or not depleted 
of HuR expression were treated with 1     M STS for the indicated times. Western blot analyses were performed using 25   μ  g of total cell extract. The blot 
was probed with antibodies against HuR and PARP. Representative results of three independent experiments are shown. The percentage of HuR knockdown 
(kdn) for each panel is indicated. Bars, 20     m.     
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caspases cooperate to cause HuR cleavage in vivo, we depleted 
their expression in HeLa cells using specifi  c siRNA duplexes. 
These cells were then treated with 1     M STS for various peri-
ods of time and harvested to prepare total cell extracts. Western 
blot analysis using the anti-HuR or anti  –  caspase-3 or -7 anti-
bodies demonstrated that the depletion of caspase-3 or -7 sig-
nifi  cantly reduced STS-mediated HuR cleavage (  Fig. 2 D  , 
lanes 5, 6, 8, and 9). Additionally, we observed that in siRNA  –
 caspase-7 – treated cells, the processing of caspase-3 was signifi  -
cantly reduced (  Fig. 2 D  , lanes 6 and 9). Likewise, the cleavage 
of caspase-7 was reduced in caspase-3 knockdown cells. These 
results suggested that in vivo, both caspase-7 and -3 are needed 
for the cleavage of HuR. 
  The epitope recognized by the monoclonal anti-HuR anti-
body (3A2) is located in RRM1 of HuR (  Gallouzi et al., 2000  ). 
Therefore, our experiment showing that 3A2 also specifi  cally 
recognized the 24-kD fragment (  Figs. 1 F and 2 A  ) is an indica-
tion that the C-terminal region of HuR is likely to harbor the 
caspase-dependent cleavage site. To test this possibility, we pre-
pared several deletion mutants of the HuR protein that were 
N-terminally tagged with GFP (  Fig. 3 A  ). HeLa cells overexpress-
ing equal amounts of these mutants (  Fig. 3 B  , lanes 1  –  4) were 
treated with 1     M STS for 3 h (  Fig. 3 B  , lanes 5  –  8) and har-
vested to prepare total cell extracts. Western blot analyses using 
antibodies against GFP (  Fig. 3 B  ) showed that STS treatment 
generated a CP with GFP-HuR    RRM1-RRM2 (  Fig. 3 B  , lane 6) 
and GFP-wt-HuR (  Fig. 3 B  , lane 8) but not with the other mu-
tants. Furthermore, as with endogenous HuR (  Figs. 1 F and 2 A  ), 
the CPs are     9 kD smaller than the precursor proteins (  Fig. 3 B  , 
lanes 6 and 8). Because the calculated molecular mass of the 
HNS-RRM3 domain is 13.6 kD, these results support the exis-
tence of a caspase cleavage site within or close to the HNS mo-
tif of HuR (  Fig. 3, A and B  ). 
  Caspases recognize a four  –  amino acid sequence in their 
targets and cleave at an aspartic acid residue (D) located at the 
P1 position with respect to the scissile bond. There are three 
potential caspase cleavage sites in the HNS-RRM3 motif: 
MGVD    226     and QD    254   AD   256     (  Fig. 3 A  ). The D residues in each of 
these sites were individually mutated to alanine (A), and the 
resulting constructs were transfected into HeLa cells (  Fig. 3 C  , 
lanes 1  –  5). The following day, apoptosis was induced by 1    M 
STS for 3 h, and the appearance of HuR-CP was monitored by 
immunoblotting. Only the HuR MGVD  226 A  (HuRD 226 A)  mu-
tant was completely resistant to cleavage (  Fig. 3 C  , lane 8). 
In contrast, cleavage of the HuR mutants HuRD  254 A and HuRD  256 A 
(  Fig. 3 C  , lanes 9 and 10) were unaffected or only partially in-
hibited, respectively, suggesting that MGVD  226   constitutes the 
principal caspase-7/-3 cleavage site in HuR. Notably, over-
expressing HuR appeared to cause some cleavage of wild-type 
(wt) GFP-HuR (  Fig. 3, B   [lane 4] and C [lane 1]). This cleavage 
is most likely the result of background apoptosis caused by 
transfection with HuR. In the absence of STS, the deletion mu-
tants HuR-    HNS-RRM3 and HuR-   RRM1 – RRM2  (which  ap-
proximate the two products generated by the cleavage of HuR) 
also induced cell death by 17% and 28%, respectively (  Fig. 3 D  ). 
These data established a direct correlation between HuR cleav-
age and caspase-mediated apoptosis. 
http://www.jcb.org/cgi/content/full/jcb.200709030/DC1). Further-
more, as previously shown in HL-60 ( Xu et al., 2005 ) and in C2C12 
cells (  van der Giessen et al., 2003  ), we observed that the HeLa 
cells used in our experiments effi  ciently took up the same amount 
of both AP  –  HuR-GST and AP-GST (  >  85%; Fig. S2, B and C). 
 To  defi  ne the levels at which HuR affects apoptosis, we 
examined the processing of caspase-3 by Western blot analysis 
in cells expressing or not expressing HuR. Caspase-3 is one of 
the main executioner caspases that is processed by the apopto-
some complex to generate a cleavage product (CP; caspase-3  –
  CP) that represents the active form of the enzyme (  Zou et al., 
1997  ). HeLa cells treated with siRNA-HuR or siRNA-C were 
incubated for 3 h with 1     M STS. Total extracts were then 
prepared and used for Western blot analysis. We observed that 
in HuR-depleted cells, the cleavage of caspase-3 was signifi  -
cantly reduced compared with the control (  Fig. 1 E  , lanes 
3 and 4). We also examined the processing of a well-characterized 
caspase-3 target, poly(ADP-ribose) polymerase (PARP; a 
DNA repair enzyme;   Janicke et al., 1998  ). We observed that 
PARP cleavage was impaired in HeLa cells lacking HuR and 
treated with 1     M STS for various periods of time (  Fig. 1 F  , 
bottom; lanes 7  –  12). Our Western blot analysis using the anti-HuR 
antibody detected the appearance of a 24-kD fragment of 
HuR only in control cells 2 h after STS treatment and not in 
HuR-depleted cells (  Fig. 1 F  , top; lanes 7  –  12). This suggested 
that HuR itself could be a target for cleavage during caspase-
mediated apoptosis. Thus, we investigated the link between 
the effect of HuR on apoptosis and the appearance of this 
24-kD fragment. 
  Both caspase-7 and -3 are required for 
the cleavage of HuR at the MGVD  226   site 
located in the HNS domain 
  To observe this 24-kD fragment of HuR by Western blot analy-
sis, at least 25   μ  g of cell extract was required. Because this 
quantity is 10-fold higher than normally used to detect full-
length HuR, it is likely that only a small portion of the protein 
is cleaved to generate this stress-induced fragment. To defi  ne 
whether the appearance of this fragment correlates with caspase 
activity, we prepared total extracts from HeLa cells treated or 
not treated with 1     M STS for 3 h in the absence or presence 
of the pancaspase inhibitor zVAD-FMK (  Chipuk and Green, 
2005  ). We observed that adding zVAD to STS-treated HeLa 
cells led to a signifi  cant reduction (  >      75%) in the intensity of 
the 24-kD band (HuR-CP;   Fig. 2 A  ). Thus, we concluded that 
this fragment could be a caspase-generated CP of HuR. To de-
termine which caspase was responsible for this cleavage activ-
ity, we fi  rst performed an in vitro cleavage assay using in vitro 
synthesized [ 
35  S]methionine-labeled HuR and a set of recombi-
nant human caspases. Despite the fact that both caspase-7 and -3 
cleaved the  
35  S-labeled PARP (  Fig. 2 C  ), only caspase-7 
cleaved HuR (  Fig. 2 B,   compare lane 6 with lanes 1  –  5 and 7  –  9). 
Even when the concentrations of other caspases were in-
creased twofold, no HuR cleavage was seen (unpublished data). 
Caspase-3 and -7 have been shown in many cell systems to have a 
functional redundancy or to collaborate to cleave their target 
proteins (  Lakhani et al., 2006  ). To investigate whether these two 117 THE ROLE OF H  U  R CLEAVAGE IN APOPTOSIS   •   MAZROUI ET AL.
ates the nucleocytoplasmic traffi  cking of HuR (  Fan and Steitz, 
1998  ), we tested the link between this cellular relocalization 
and the caspase-mediated cleavage of HuR. HeLa cells over-
expressing equal amounts of GFP-HuR and -HuRD  226 A  ( Fig.  3  C , 
lanes 1 and 3) were treated with 1     M STS for 3 h and fixed. 
We observed that both proteins translocated into the cytoplasm 
upon STS treatment (  Fig. 4 A  ), indicating that the D  226 A  muta-
tion does not affect the cellular movement of HuR. We were 
  HuR accumulates in the cytoplasm in 
a pp32/PHAP-I  –  dependent manner in 
response to STS 
  The aforementioned experiments indicated that under apoptotic 
conditions, HuR is cleaved at the D  226   residue located in its 
HNS domain. It has been shown that under stresses such as HS 
and UV, HuR accumulates partially in the cytoplasm (  Gallouzi 
et al., 2000  ;   Wang et al., 2000  ). Because the HNS region medi-
  Figure 2.       Although only caspase-7 cleaves HuR in vitro, both 
caspase-3 and -7 are needed for the cleavage of HuR in HeLa 
cells.   (A) Active caspases are required for the appearance 
of the 24-kD fragment. Cells were incubated with DMSO 
(lane 1), zVAD (lane 2), STS (lane 3), or with both zVAD 
and STS (lane 4). Western blotting for HuR was performed 
as described in Fig. 1 A. (B and C) In vitro caspase cleav-
age assay. (B) [ 
35  S]methionine-labeled HuR was incubated 
for 3 h at 37  °  C with 5 U of puriﬁ  ed recombinant caspases 
(C-1  –  10). Samples were applied to SDS-polyacrylamide 
gels, and HuR cleavage was visualized by autoradiography. 
(C) [ 
35  S]methionine-labeled PARP was incubated for 3 h at 37  °  C 
with 5 U of puriﬁ  ed recombinant caspase-7 and -3. Samples 
were analyzed as described in B. (D) The effect of caspase-7 
and -3 knockdown on HuR cleavage. HeLa cells were trans-
fected with RNAi duplexes against caspase-7 (siRNA  –  C-7) 
or caspase-3 (siRNA  –  C-3) mRNA as well as control siRNA 
(siRNA-Ctr). 48 h later, they were treated with 1     M STS for 
3 h and were harvested to prepare total cell extracts. Western 
blot analyses were performed using antibodies against 
HuR, caspase-7, and caspase-3 proteins. The percentage of 
caspase-7 and -3 knockdown (% kdn) is indicated. (A  –  D) Rep-
resentative results of three independent experiments for each 
panel are shown.     JCB • VOLUME 180 • NUMBER 1 • 2008  118
under which cell shrinkage and caspase activities were not 
visible (  Figs. 1 F   [lanes 4 and 6] and   4 B   [panel 6]). This obser-
vation was further supported by biochemical fractionation 
experiments. Nuclear and cytoplasmic fractions were obtained 
from HeLa cells treated or not treated with 1     M STS for 3 h, 
and Western blot analysis showed that the levels of HuR in-
crease in the cytoplasm upon STS treatment (  Fig. 4 C  , lanes 5 
and 6). We also observed that the 24-kD fragment was detected 
only in the cytoplasmic fraction (  Fig. 4 C  , lanes 4 and 6). These 
results, together with the fact that zVAD did not prevent the STS-
induced translocation of HuR in the cytoplasm (Fig. S4, available 
surprised to observe that HuR showed a diffused cytoplasmic 
staining upon STS treatment rather than being localized to 
stress granules (stress-induced cytoplasmic foci;   Anderson and 
Kedersha, 2006  ), as was shown with other stresses (  Gallouzi et al., 
2000  ). To verify whether endogenous HuR behaves similarly to 
GFP-wt-HuR, HeLa cells were treated with 1     M STS for vari-
ous periods of time, and immunofl  uorescence experiments were 
performed using the anti-HuR antibody. As with GFP-HuR, STS 
treatment induced a rapid appearance of endogenous HuR into 
the cytoplasm (  Fig. 4 B  ). The cytoplasmic translocation of HuR 
was detectable as early as 1 h after STS treatment, conditions 
  Figure 3.       Substituting the amino acid residue aspartate 226 with alanine protects HuR from caspase-mediated cleavage.   (A) Schematic diagram of 
the structure of full-length HuR fused to GFP as well as the deletion and point mutants. The positions of the Asp (D) mutated to Ala (A) are underlined. 
The functional domains of HuR are shown. Numbers refer to the amino acid sequences of the protein. (B) HuR is cleaved in its HNS domain. GFP-HuR and its 
truncated forms were expressed in HeLa cells. Subsequently, the cells were treated or not treated with 1     M STS for 3 h. Immunoblot analysis was performed 
using anti-GFP antibodies. (C) The D  226   residue is required for HuR cleavage. GFP, GFP-HuR, and its point mutation derivatives were produced in HeLa cells. 
Subsequently, the cells were treated with 1     M STS for 3 h (right) or were left untreated (left). GFP and GFP-HuR proteins were detected by immunoblotting 
using anti-GFP antibodies. The white line indicates that intervening lanes have been spliced out. (D) Overexpression of the HuR CPs enhances cell death. 
HeLa cells grown under normal conditions were mock transfected (    ) or transfected with GFP-HuR, GFP-HuR-    HNS-RRM3, or GFP-HuR    RRM2  –  RRM3. 48 h after 
transfection, cells were ﬁ  xed and DAPI stained. Percent death was calculated by counting the number of fragmented nuclei and expressing this number as a 
percentage of the total number of cells in a given ﬁ  eld. Data are represented as means of three experiments   ±   SEM (error bars).     119 THE ROLE OF H  U  R CLEAVAGE IN APOPTOSIS   •   MAZROUI ET AL.
at http://www.jcb.org/cgi/content/full/jcb.200709030/DC1), 
suggested that during apoptosis, the cellular movement of HuR 
is independent of caspase activity. 
  Previous studies have suggested that HuR uses two path-
ways to translocate from the nucleus to the cytoplasm (  Gallouzi 
and Steitz, 2001; Gallouzi et al., 2001  ;   Higashino et al., 2005; 
Fries et al., 2006)  . One pathway involves the receptor CRM1 as 
well as HuR protein ligands pp32/PHAP-I and APRIL, whereas 
the other pathway involves an as yet unknown transport factor 
(  Gallouzi and Steitz, 2001; Gallouzi et al., 2001  ;   Fries et al., 
2006 ). Under stress, however, HuR uses mainly the CRM1 route 
to go from the nucleus to the cytoplasm (  Gallouzi et al., 2001  ; 
  Higashino et al., 2005  ). To test whether this is also the case 
upon STS stress, we followed the cellular distribution of HuR 
and its ligands pp32/PHAP-I and APRIL. HeLa cells were 
treated or not treated with 1     M STS for 3 h, fi  xed, and used for 
immunofl  uorescence experiments with antibodies against HuR, 
pp32/PHAP-I, or APRIL. We observed that both HuR and pp32/
PHAP-I colocalized in the nucleus under normal conditions 
(  Fig. 5 A  , panels 1  –  3) as well as in the cytoplasm upon STS 
treatment (  Fig. 5 A  , panels 5  –  7). However, HuR and APRIL co-
localized only in the nucleus before and after stress (  Fig. 5 A  , 
panels 9  –  11 and 13  –  15). These results were confi  rmed using 
cell fractionation and Western blot analysis (unpublished data). 
Because pp32/PHAP-I associates with the NHS motif of HuR 
and has been reported as an activator of the apoptosome (  Jiang 
et al., 2003  ), we tested its role in both HuR cytoplasmic trans-
location and caspase activation. HeLa cells treated with siRNA-
pp32/PHAP-I or siRNA-C were incubated or not incubated with 
1     M STS and were used for immunofl  uorescence experiments 
with antibodies against HuR and pp32/PHAP-I. Although knock-
ing down pp32/PHAP-I by   >  50% did not affect the nuclear lo-
calization of HuR under normal conditions, the cytoplasmic 
translocation of HuR was signifi  cantly reduced upon STS treat-
ment (  Fig. 5 B  , panels 5 and 13). Western blot analysis showed 
a signifi  cant reduction in the cleavage of both PARP and HuR in 
siRNA-pp32/PHAP-I  –  treated cells that were exposed to STS 
for 3 h (  Fig. 5 C  ). Therefore, our observations indicated that in 
addition to being involved in the nucleocytoplasmic movement 
of HuR, pp32/PHAP-I also affects the caspase activation that is 
required for HuR cleavage. 
  HuR enhances apoptosome activity via its 
interaction with pp32/PHAP-I 
  Our knockdown and rescue experiments (  Fig. 1  ) suggested 
that HuR plays a role in the cellular processes responsible for 
the activation of apoptosis. Because we have shown that pp32/
PHAP-I interacts with HuR before and after stress (  Gallouzi 
et al., 2001  ), it was possible that pp32/PHAP-I was involved in 
the proapoptotic function of HuR. To test this possibility, we re-
constituted the apoptosome in a cell-free system and examined 
  Figure 4.       The caspase-mediated cleavage of HuR is a cytoplasmic event. 
  (A) Like wt GFP-HuR, GFP-HuRD  226  A accumulates in the cytoplasm upon 
STS treatment. HeLa cells were transfected with GFP-HuR (a  –  d) or GFP-
HuRD  226  A (e  –  h). 48 h after transfection, cells were treated with 1     M STS 
as indicated. DAPI staining shows nuclei. Representative images of two 
independent experiments are shown for each time point. (B) STS induces 
the cytoplasmic accumulation of endogenous HuR. Cells were treated with 
STS for the indicated times and were ﬁ  xed and processed for immunoﬂ  uor-
escence using antibodies against HuR and the cytoplasmic protein G3BP. 
DAPI staining depicts nuclei. Representative images of four independent 
experiments are shown for each time point. (C) The HuR 24-kD CP is de-
tected only in the cytoplasmic fraction. STS-treated cells were harvested 
at each indicated time point and lysed to prepare cellular fractions. Cyto-
plasmic and nuclear fractions were prepared and loaded on a 10% SDS-
PAGE. Western blot analysis was performed to detect HuR. The anti-tubulin 
(cytoplasmic marker), -hnRNAP A1 (nuclear marker), and   –      -actin (loading 
control) antibodies were used to assess equal protein loading among cel-
lular fractions. Representative Western blots of three independent experi-
ments are shown. TE, total cellular extract. Bars, 20     m.     
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  Figure 5.       Both the cytoplasmic accumulation of HuR and its caspase-7/-3  –  mediated cleavage depend on pp32/PHAP-I protein.   (A) STS treatment induces 
the cytoplasmic colocalization of HuR with pp32/PHAP-I but not with its ligand APRIL. Untreated cells or STS-treated HeLa cells were ﬁ  xed and processed 
for immunoﬂ  uorescence to detect HuR, pp32/PHAP-I, and APRIL. (B) The knockdown of pp32/PHAP-I prevents the cytoplasmic accumulation of HuR upon 
STS treatment. HeLa cells were transfected with RNAi duplexes against pp32/PHAP-I mRNA (siRNA-pp32) or control siRNA (siRNA-Ctr), and, 48 h later, 
they were treated with 1     M STS for 3 h. Subsequently, these cells were ﬁ  xed and used for immunoﬂ  uorescence experiments with anti-HuR and -pp32/
PHAP-I antibodies. Representative images of two independent experiments are shown for each time point. (C) siRNA-mediated depletion of pp32/PHAP-I 
results in the reduction of PARP and HuR cleavage. HeLa cells were transfected with RNAi duplexes as described in B. Western blot analyses using the 121 THE ROLE OF H  U  R CLEAVAGE IN APOPTOSIS   •   MAZROUI ET AL.
precipitation experiment with the anti-pp32/PHAP-I antibody. 
As expected, the overexpression of GFP-wt-HuR induced its 
own cleavage, and an association with pp32/PHAP-I was ob-
served (  Fig. 8 A  , lanes 1 and 2). Furthermore, we also observed 
that the GFP-HuRD  226  A association with pp32/PHAP-I was 
fourfold higher compared with the interaction between pp32/
PHAP-I and GFP-wt-HuR (  Fig. 8 A  , compare lane 2 with lane 4). 
This observation suggested that by increasing its association 
with pp32/PHAP-I, HuRD  226  A could interfere with the apoptotic 
process. To test this possibility, HeLa cells overexpressing GFP-
wt-HuR, GFP-HuRD  254 A,  GFP-HuRD 256  A, or GFP-HuRD  226 A 
were treated with a sublethal dose of STS (0.1     M) for 3 h. We 
observed that although PARP cleavage was induced by the cleav-
able isoforms of HuR protein (wt, D  254  A, and D  256  A), it was sig-
nifi  cantly reduced by the noncleavable isoform GFP-HuRD  226 A 
(  Fig. 8 B  , compare lanes 3, 5, and 6 with lane 4). In addition, the 
HuRD  226  A mutant seemed to affect apoptosis by reducing the 
processing of caspase-3. HeLa cells expressing GFP-HuRD  226 A, 
GFP-wt-HuR, or GFP alone were treated with STS for different 
times, and the apoptosome activity was assessed (  Schafer and 
Kornbluth, 2006  ). At early stages of the apoptotic response 
(between 1 and 2 h of STS treatment), we observed only a basal 
level of caspase-3 activity (  Fig. 8 C  ). However, at later stages 
(between 2 and 3 h and thereafter), we observed that caspase-3 
activity was significantly reduced in the presence of GFP-
HuRD  226  A (S100 + DA) compared with GFP-wt-HuR (S100 + 
HuR) or GFP (S100) alone (  Fig. 8 C  ). These results suggested 
that HuRD  226 A  signifi  cantly reduced the activation of the apop-
tosome (here between 2 and 3 h of STS treatment). These obser-
vations were further confirmed by Western blot analysis of 
caspase-3 cleavage in the same cells (  Fig. 8 D  ). Thus, preventing 
HuR cleavage seems to negatively affect apoptosis. In addition, 
the signifi  cant increase in association between HuRD  226 A  and 
pp32/PHAP-I was a good indication that the HuR  –  pp32/PHAP-I 
complex played an important role in the activation of apoptosis. 
  To determine whether the HuRD  226  A mutant might inter-
fere with the proapoptotic function of endogenous HuR under 
these extreme conditions, we performed a rescue experiment as 
described in   Fig. 1  . HeLa cells depleted of HuR protein were 
incubated  with  AP – HuR-GST  or  AP – HuRD 226  A-GST for 16 h 
before STS treatment. Western blot analysis using anti-PARP 
antibody showed that although AP  –  HuR-GST alone increased 
caspase-3 activity, the addition of AP  –  HuRD  226  A-GST to these 
cells signifi  cantly reduced its activity and PARP cleavage (  Fig. 
8 E  ). This was also addressed in vivo by defi  ning the percentage 
of cell death of HeLa cells incubated with 50 nM AP  –  HuR-
GST  or AP – HuRD 226  A-GST and exposed to 1     M STS for 3 h. 
The phase-contrast pictures showed that compared with AP  –
 HuR-GST, AP – HuRD 226 A-GST signifi  cantly reduced cell death 
(  Fig. 8 F  , compare panels c and g with panels d and h). These 
observations indicated that mutating the D  226   to  A  not  only 
protected HuR against cleavage but also delayed caspase-
dependent apoptosis. 
the effect of PHAP-I depletion on caspase-3 activity. To deplete 
pp32/PHAP-I, S100 extracts were incubated with GST-HuR or 
GST alone immobilized on a glutathione bead column and were 
used in an in vitro reconstitution assay of the apoptosome in the 
presence of cyt   c   and dATP (Fig. S5, available at http://www.jcb
.org/cgi/content/full/jcb.200709030/DC1). In this assay we fol-
lowed the release of a fl  uorophore (7-amino-4-methylcoumarin 
[AMC]) off the DEVD peptide (caspase-3 cleavage target site; 
 Schafer and Kornbluth, 2006 ). Western blot analysis showed that 
the GST-HuR column depleted   >  80% of pp32/PHAP-I from the 
S100 extract compared with GST alone (  Fig. 6 A  , lanes 1 and 2). 
In contrast to the controls (  Fig. 6 B  , bars 2 and 3), the pp32/
PHAP-I  –  depleted S100 extracts displayed weaker apoptosome 
activity in the presence of cyt   c  /dATP, as illustrated by reduced 
levels of hydrolysis of the caspase-3 substrate DEVD-AMC 
( Fig. 6 B , compare bar 4 with bars 2 and 3). This reduction is due 
specifi  cally to the absence of pp32/PHAP-I because the addition 
of recombinant GST-pp32/PHAP-I to this extract ( Fig. 6 B , bar 5) 
was able to reestablish the apoptosome activity to almost its nor-
mal level. The addition of GST-HuR with or without GST-pp32/
PHAP-I to the pp32/PHAP-I  –  depleted S100 extract rescued the 
apoptosome activity to the same levels seen upon the addition of 
GST-pp32/PHAP-I alone (  Fig. 6 B  , compare bars 6 and 7 with 
bar 5). These observations suggested that the enhancement of 
apoptosome activity mediated by the pp32/PHAP-I  –  HuR com-
plex reaches a threshold that cannot be potentiated. 
  Subsequently, we wished to test the effect of HuR CPs 
(HuR-CP1 and HuR-CP2) as well as the HuRD  226  A mutant on 
apoptosome activity in the presence or absence of pp32/PHAP-I. 
We were surprised to observe that the addition of HuR-CP1 or 
-CP2 further reduced the remaining apoptosome activity seen in 
the S100-    pp32 extract (  Fig. 6 B  , compare bars 8 and 10 with 
bar 4). However, the apoptosome activity of these extracts in-
creased upon the addition of GST-pp32/PHAP-I (  Fig. 6 B  , bars 
9 and 11). The same result was obtained upon the addition of 
HuR-D  226  A (  Fig. 6 B  , compare bars 12 and 13 with bar 5). The 
fact that HuR-CP1 but not -CP2 associated with HuR in a pull-
down assay (  Fig. 7 A  ) and that HuR-CP2 but not -CP1 inter-
acted with pp32/PHAP-I in an immunoprecipitation experiment 
(  Fig. 7 B  ) indicated that the negative effect of these CPs on the 
apoptosome activity could be explained, in part, by their ability 
to interfere with HuR (CP1) or pp32/PHAP-I (CP2) functions. 
  The D  226  A mutation increases HuR 
association with pp32/PHAP-I and delays 
caspase-dependent apoptosis 
  Because the D  226  A mutation did not affect HuR cytoplasmic 
translocation under apoptotic conditions ( Fig. 5 A ) and prevented 
pp32/PHAP-I function in the apoptosome activation (  Fig. 6 B  , 
bar 13), we tested its effect on HuR-pp32/PHAP-I association. 
HeLa cells overexpressing equal amounts of GFP-wt-HuR or 
-HuRD  226  A proteins were grown under normal conditions and 
were used to prepare total cell extracts to perform an immuno-
anti-pp32/PHAP-I, -HuR, and -PARP antibodies were performed using total cell extracts prepared from STS-treated cells. The anti-G3BP antibody was used 
as a loading control. (B and C) The percentage of pp32/PHAP-I knockdown (% kdn) is indicated. Bars, 20     m.     
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  Discussion 
  Our data demonstrate that HuR plays a key role in the enhance-
ment of caspase-dependent apoptosis induced by extreme stress 
conditions. Although it is well established that HuR affects cell 
fate through its role as an RNA-binding protein (  Brennan and 
Steitz, 2001; Abdelmohsen et al., 2007  ), evaluating the possibil-
ity that HuR also functions through an alternative pathway has 
been elusive. In this study, we identify a novel regulatory mech-
anism through which HuR participates in the apoptotic path-
way. We show that HuR potentiates the apoptotic response by 
undergoing a caspase-mediated cleavage at a specifi  c aspartate 
residue located in its HNS region. This cleavage activity occurs 
only after HuR enters the cytoplasmic compartment in a pp32/
PHAP-I  –  dependent manner. HuR exerts its proapoptotic effects 
through its association with pp32/PHAP-I, a known enhancer 
of the apoptosome (  Jiang et al., 2003; Hill et al., 2004  ). Thus, we 
propose a model whereby in response to a lethal stress, HuR 
accumulates in the cytoplasm, where it undergoes caspase-
mediated cleavage. This cleavage appears to be important for 
pp32/PHAP-I – mediated enhancement of the caspase-dependent 
apoptosis (  Fig. 9  ). 
  Previous studies had shown that HuR regulates the stabil-
ity and/or the translation of mRNAs encoding for pro- (p21 
Waf1 , 
p27 
Kip1  , and p53) and antiapoptotic (proT    ) proteins (  Schiavone 
et al., 2000  ;   Wang et al., 2000; Kullmann et al., 2002  ;   Mazan-
Mamczarz et al., 2003  ;   Lal et al., 2005  ). However, no explana-
tion has been given as to how HuR may be active in these two 
opposite processes. In response to different extracellular stim-
uli, HuR associates with mRNAs encoding for proteins that are 
involved in different mechanisms such as cell cycle, cell differ-
entiation, and stress response (  van der Giessen et al., 2003; 
Abdelmohsen et al., 2007  ). Thus, the cellular function of HuR 
could vary depending on the nature of the stimuli applied. 
Consistent with this idea, we noted that knocking down the ex-
pression of HuR in cells treated with a lethal dose of STS causes 
a signifi  cant delay in caspase-dependent apoptosis ( Fig. 1 ). This ob-
servation implies that HuR promotes cell death under condi-
tions in which the integrity of the cell is altered beyond repair. 
In contrast, it has been seen that upon mild stress, HuR pro-
motes death resistance by affecting the translation of the mRNA 
encoding for proT     (  Lal et al., 2005  ). Together, these and our 
fi  ndings argue that HuR can function during the two character-
istic steps of the cell stress response. First, it participates in 
processes that activate prosurvival pathways to facilitate cell 
recovery (proT    ). Then, if the stress becomes persistent, HuR 
promotes cell death. 
  To our surprise, while delineating the cellular mechanism 
by which HuR promotes apoptosis, we observed that HuR itself 
is cleaved in a caspase-dependent manner. We found that al-
though only caspase-7 is able to cleave HuR in vitro (  Fig. 2 B  ), 
in HeLa cells, this proteolytic activity involves both caspase-7 
and -3 (  Fig. 2  ). This caspase-mediated cleavage generates frag-
ments of 24 kD (HuR-CP1) and 9 kD (HuR-CP2;   Figs. 2 and 3  ). 
These data are consistent with the well-established notion that 
the cleavage cascade requiring a series of caspases represents a 
key process needed to generate active proapoptotic proteins. 
  Figure 6.       Association between HuR and pp32/PHAP-I is part of the regu-
latory mechanism leading to pp32/PHAP-I  –  mediated apoptosome activa-
tion.   (A) Western blot analysis using the ﬂ  ow-through (lanes 1 and 2) or the 
pellets (lanes 3 and 4) prepared from S100 extracts incubated with GST-
HuR or GST beads was performed using the anti-pp32/PHAP-I antibody. 
Detection of the cytoplasmic protein G3BP was used as a loading control. 
(B) S100 extracts were incubated with GST-HuR, GST, or buffer A alone 
for 16 h. The resulting ﬂ  ow-throughs, S100-depleted pp32 (S100-    pp32), 
S100 mock depleted (Mock-S100), and S100 extracts were then incu-
bated with 1     g cyt   c  /1.5 mM dATP for 2 h at 30  °  C. For S100-    pp32, 
the following proteins were added before incubation: GST-pp32 (bar 5), 
GST-HuR (bar 6), GST-pp32 and -HuR (bar 7), GST  –  HuR-CP1 (bar 8), GST-
pp32 and   –  HuR-CP1 (bar 9), GST  –  HuR-CP2 (bar 10), GST-pp32 and 
-HCP2 (bar 11), GST-HuR-D  226  A (bar 12), GST-pp32 and -HuR-D  226  A (bar 13), 
and GST and -pp32 (bar 14). Apoptosome activation was monitored via 
cleavage of the ﬂ  uorometric-conjugated caspase-3 substrate DEVD-AMC. 
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with pp32/PHAP-I (  Brennan et al., 2000  ). Thus, it is possible 
that by cleaving HuR within its HNS motif, caspase-7/-3 induce 
the release of an active part of HuR that participates in pp32/
PHAP-I  –  mediated apoptosome activation. This is likely the 
case because overexpressing the noncleavable isoform of HuR, 
HuRD  226  A, in HeLa cells delays the STS-induced cell death and 
stabilizes the pp32/PHAP-I  –  HuR complex in the cytoplasm 
(  Fig. 8  ). Moreover, interfering with apoptosome activation by 
depleting the expression of pp32/PHAP-I using RNAi signifi  -
cantly reduces the cleavage of both HuR and PARP proteins 
(  Fig. 5 C  ). These and our in vitro depletion/rescue experiments 
(  Fig. 6  ) argue that HuR plays a critical role in activating the 
apoptosome complex via its association with pp32/PHAP-I. 
The results described herein shed light on a new player involved 
in the stimulatory effect of pp32/PHAP-I on the apoptosome. 
However, pp32/PHAP-I does not directly interact with any of 
the apoptosome components (  Hill et al., 2004  ), and an apopto-
some-activating mechanism remains unknown. It was demon-
strated that the same C-terminal acidic domain of pp32/PHAP-I 
that is critical for its proapoptotic activity (  Hill et al., 2004  ) is 
also involved in its association with HuR (  Brennan et al., 2000  ). 
Our data suggest that the cleavage of HuR plays an important 
role in the proapoptotic function of pp32/PHAP-I. 
  Our data showing that RNAi-mediated depletion of pp32/
PHAP-I leads to a signifi  cant reduction in PARP and HuR 
cleavage (  Fig. 5 C  ) argue that an active apoptosome is required 
Our results argue that cytoplasmic HuR becomes a member of 
this family of cell death effectors that are induced by caspase-
mediated cleavage. HuR has features of a caspase target protein, 
such as a specifi  c aspartate residue (D  226  ) cleavage site as well 
as the generation of active CPs (  Figs. 3 and 8  ). Surprisingly, 
mutating this residue to alanine not only protected HuR protein 
from proteolysis (  Fig. 3 C  ) but also generated a noncleavable 
isoform that is able to interfere with its role in apoptosis (  Figs. 
6 and 8  ). Together, these data suggest that as soon as a lethal 
stress is applied, HuR partially migrates to the cytoplasm and 
participates in activation of the apoptotic machinery to promote 
cell death (  Figs. 3  –  5  ). 
  Activation of the apoptosome is a cytoplasmic event that 
involves Apaf-1 oligomerization upon cyt   c   release from the mi-
tochondria (  Cain et al., 2002  ). It has been shown that HuR asso-
ciates with the apoptosome activator pp32/PHAP-I through its 
HNS and RRM3 motifs (  Brennan et al., 2000  ). Here, we ob-
served that HuR diffuses and colocalizes in the cytoplasm with 
pp32/PHAP-I upon STS treatment (  Fig. 5  ). Knocking down the 
expression of pp32/PHAP-I protein signifi  cantly reduces the 
cytoplasmic accumulation of HuR. This is consistent with pre-
viously published data showing that pp32/PHAP-I is part of the 
HuR complex that translocates to the cytoplasm under different 
stress conditions (  Gallouzi et al., 2000, 2001  ). Likewise, we 
found that the percentage of total HuR that is cleaved in the cy-
toplasm (  Fig. 3  ) corresponds to the same amount that associates 
  Figure 7.       HuR and pp32/PHAP-I differentially as-
sociate with HuR-CP1 and -CP2.   (A) HuR-CP1 but not 
HuR-CP2 associates with HuR in GST pull-down as-
says. S100 extracts were incubated with GST, GST  – 
HuR-CP1 (HCP1), and  –  HuR-CP2 (HCP2) beads for 16 h.
The resulting ﬂ   ow-through (lanes 1  –  3) and pellets 
(lanes 4  –  6) were analyzed by Western blotting us-
ing anti-HuR and -G3BP (loading control) antibodies. 
(B) HuR-CP2 but not HuR-CP1 associates with pp32/
PHAP1 in vivo. HeLa cells were transfected with GFP-
HCP1 (lanes 1 and 2) or GFP-HCP2 (lanes 3 and 4). 
48 h after transfection, extracts were subjected to 
immunoprecipitation using anti-pp32/PHAP-I antibodies. 
The immunoprecipitates (P) and supernatants (S) were 
analyzed by Western blotting using anti-GFP and -pp32/
PHAP-I antibodies. LC and HC indicate light chains 
and heavy chains of the anti-pp32/PHAP-I antibody, 
respectively. Arrowheads indicate the positions of 
GFP-HCP1, GFP-HCP2, and pp32/PHAP-I proteins.     JCB • VOLUME 180 • NUMBER 1 • 2008  124
  Figure 8.       HuRD  226  A maintains a strong interaction with pp32/PHAP-I and delays apoptosis.   (A) HuRD  226  A associates with pp32/PHAP-I with higher 
efﬁ  ciency than wt-HuR. HeLa cells were transfected with GFP-HuR (lanes 1 and 2) or GFP-HuRD  226  A (lanes 3 and 4). 48 h after transfection, extracts were 
subjected to immunoprecipitation using anti-pp32/PHAP-I (lanes 1  –  4) or IgG (lanes 5 and 6) antibodies. The immunoprecipitates (P) and supernatants (S) 
were analyzed by Western blotting using anti-HuR (3A2) antibody. (B) HuRD  226  A reduces PARP cleavage. GFP, GFP-HuR, and its point mutation derivatives 
were produced in HeLa cells. The cells were then treated with 0.1     M STS for 3 h. GFP and GFP-HuR proteins were detected by immunoblotting using anti-
GFP, -PARP, and -G3BP (loading control) antibodies. (C and D) HeLa cells expressing GFP, GFP-HuR, or GFP-HuRD  226  A were treated with 1     M STS for the 
indicated times. 100     g of total cytoplasmic extracts were incubated with 10     M DEVD-AMC ﬂ  uorogenic peptide, and the release of AMC was measured 
over 30 min. Error bars represent SEM. AFU, arbitrary ﬂ  uorescence unit. (D) Western blot analysis of the cleavage of caspase-3 by immunoblotting using 125 THE ROLE OF H  U  R CLEAVAGE IN APOPTOSIS   •   MAZROUI ET AL.
    HNS-RRM3, forward (5    -GGCAGATCTAATGGTTATGAAGACCACA-3    ) 
and reverse (5    -GGCGAATTCTTAGTACAGCTGCGAGAGGAG-3    ); GFP-
HuR-    RRM1  –  RRM2, forward (5    -GGCAGATCTTACCACTCGCCAGCG-
CGA-3    ) and reverse (5    -GGCGAATTCTTATTTGTGGGACTTGTTGGTT-3    ); 
and GFP-HuR-    RRM3, forward (5    -GGCAGATCTAATGGTTATGAAGAC-
CACA-3    ) and reverse (5    -GGCGAATTCTTAGGAGGAGGCGTTTCCTGG-3    ).
The point mutants GFP-HuRD  226  A, GFP-HuRD254A, and GFP-HuRD256A 
were generated by Norclone Biotech Laboratories. AP  –  HuR-GST and AP  –
  HuRD  226  A-GST were produced and used as described previously (  van der 
Giessen et al., 2003  ). GST-HCP1 and GST-HCP2 plasmids were constructed, 
and proteins were produced as follows: the ﬁ  rst 226 amino acids of HuR (1  –
  226; HCP1) or the last 100 amino acids (227  –  326; HCP2) were ampliﬁ  ed 
by PCR using wt HuR as the template. A BglII site was created at the 3     end, 
and an EcoRI site was generated at the 5     end of the PCR product for both 
HCP1 and HCP2. GFP-HCP1 was generated using the primers forward 
(5    -GGCAGATCTAATGGTTATGAAGACCACA-3    ) and reverse (5    -GGC-
GAATTCTTAATCGACGCCCATGGG-3    ). We generated GFP-HCP2 using 
the primers forward (5    -GGCAGATCTCACATGAGCGGGCTCTCT-3    ) and 
reverse (5    -GGCGAATTCTTAGTACAGCTGCGAGAGGAG-3    ). Those PCR 
fragments were cloned within the BglII  –  EcoRI sites of pAcGFP1-C1 vector (BD 
Biosciences), and both fragments were inserted in frame of the GFP gene. 
  Cell culture, transfection, and stress treatments 
  HeLa CCL-2 cells (American Type Culture Collection) were grown and 
maintained in DME (Invitrogen) containing 10% FBS (Invitrogen), penicillin/
streptomycin, and   L-  glutamine according to the manufacturer  ’  s directions 
(Sigma-Aldrich). DNA and siRNA-HuR duplexes were transfected into 
HeLa cells as described previously (  van der Giessen et al., 2003  ) except 
that 60 nM of each siRNA-HuR duplex was transfected into cells. The 
knockdown of pp32/PHAP1, caspase-7, and caspase-3 expression was 
performed using a premade siRNA duplex (QIAGEN). The experiments 
were performed according the manufacturer  ’  s instructions. 
  For the rescue experiments, subconﬂ  uent HeLa cells depleted or not 
depleted of HuR protein were incubated in culture media with 50 nM AP-
HuR or AP-HuRD  226  A. These cells were incubated with the AP-conjugated 
proteins for 16 h and were stressed with 1     M STS (Sigma-Aldrich) as indi-
cated. zVAD and MG132 were obtained from Sigma-Aldrich. 
for HuR proteolysis. These observations suggest two possibilities: 
(1) at early stages of the cell stress response, a basal apoptosome 
activity could be present in HeLa cells, resulting in caspase-7/-3 
activation before the apoptosome reaches its full capacity; and 
(2) caspase-7/-3 could be activated in an apoptosome-independent 
manner. Our time-course experiments, in which we followed 
caspase-3 processing during cell response to STS treatment, 
favor the fi  rst possibility. We observed that at early stages (  <  100 
min) of apoptotic response, when HuR localizes to the cyto-
plasm, the apoptosome harbors a basal level of activity (  Fig. 8 C  ). 
However, at later stages (  >  100 min), we observed a signifi  cant 
increase in caspase-3 activation (  Fig. 8, C and D  ), correlating 
with the appearance of HuR-CP1 (  Fig. 1 F  ). These observations 
imply that the small amount of activated caspase-7/-3 at early 
stages of apoptosis could be suffi  cient to cleave HuR, generating 
the HuR-proapoptotic active forms. This form will then participate 
in the amplifi  cation loop that enhances the apoptosome activity, 
which feeds down on more HuR processing during apoptosis. 
  Although our data argue that HuR promotes apoptosis 
through a mechanism that is independent of its RNA-binding 
activity, we cannot rule out the possibility that the HuR CPs 
enhance apoptosis by also posttranscriptionally affecting the 
expression of some proapoptotic mRNAs. Indeed, recent obser-
vations indicated that the depletion of HuR results in a signifi  -
cant decrease in the expression of caspase-9 mRNA and protein 
(unpublished data). This suggested that HuR, through its RNA-
binding activity, could also affect apoptosome formation. Thus, 
through their RNA-binding motifs, HuR-CP1 (RRM1  –  RRM2) 
or HuR-CP2 (RRM3;   Fig. 3  ) could affect the stability and/or the 
translation of proapoptotic mRNAs. This suggests a model in 
which the caspase-mediated HuR cleavage represents the regula-
tory step during which HuR switches from an antiapoptotic func-
tion at early steps of the stress response to a proapoptotic role 
when cell death is unavoidable. This raises the possibility that in 
cancer cells, the cleavage of HuR could be altered, such as by 
a mutation to yield a noncleavable isoform and/or a defect 
in caspase-7/-3 activity, interfering with its RNA- and protein-
mediated proapoptotic function. Therefore, investigating the effect 
of cell transformation on HuR functions as a proapoptotic factor 
will open the door to the possibility of defi  ning posttranscrip-
tional regulators as potential targets for cancer therapy. 
  Materials and methods 
  Plasmid construction and protein puriﬁ  cation 
  GFP-conjugated constructs were prepared using GST-HuR plasmid as a tem-
plate (  Brennan et al., 2000  ). All primers were generated with restriction sites 
in their 5     end, BglII (forward), and EcoRI (reverse), and the products were 
cloned into pAcGFP1-C1 vector (BD Biosciences). GFP-wt-HuR was gener-
ated using the primers forward (5    -GGCAGATCTAATGGTTATGAAGAC-
CACA-3    ) and reverse (5    -GGCGAATTCTTATTTGTGGGACTTGTTGGTT-3    ). 
We generated three deletion mutants using the following primers: GFP-HuR-
anticaspase-3 antibody. (E and F) The HuRD  226  A mutant interferes with the stimulatory function of HuR on apoptosis. (E) 50 nM AP  –  HuR-GST (lanes 2 and 4) 
or AP  –  HuRD  226  A-GST (lanes 1 and 3) was added to siRNA-HuR or -Ctr STS-treated HeLa cells. Total extracts from these cells were prepared and used 
for Western blot analyses to follow PARP cleavage. The blots were probed with antibodies against HuR and PARP. (F) Phase-contrast images were taken 
from the same cells described in E. The percentage of cell death was determined as described in   Fig. 1 B  . For each panel, ﬁ  ve randomly chosen ﬁ  elds of 
300 cells were counted before and after STS treatment. Values are the means   ±   SEM from three independent experiments. (E and F) The percentage of HuR 
knockdown (% kdn) for these two panels is indicated under panel E.     
    
  Figure 9.       Model of how HuR protein participates in the pp32/PHAP-I  –
  mediated enhancement of apoptosome activity.   Upon induction of stress-
induced apoptosis, HuR and its partner pp32/PHAP-I translocate together to 
the cytoplasm. In the cytoplasm, HuR is targeted for cleavage in a process 
involving both capase-7 and -3. This cleavage event contributes to the 
pp32/PHAP-I  –  mediated enhancement of apoptosome activity. How HuR 
and/or its CPs participate with pp32/PHAP-I in cell death by apoptosis is 
under investigation.     JCB • VOLUME 180 • NUMBER 1 • 2008  126
  Online supplemental material 
  Fig. S1 shows that HeLa cells depleted of HuR and exposed to HS (45  °   
for 1 h) present a signiﬁ  cant delay in triggering caspase-mediated apop-
tosis. Fig. S2 shows that the concentration (50 nM) of AP  –  HuR-GST and 
AP-GST used in the rescue experiments is not toxic to the cells. Fig. S3 
shows that HeLa cells depleted of HuR and exposed to the proteasome 
inhibitor MG132 are resistant to death by apoptosis. Fig. S4 shows that 
the STS-induced cytoplasmic localization of HuR occurs in a caspase-
independent manner. Fig. S5 shows a schematic representation of the dif-
ferent steps of the in vitro assay for the apoptosome activity performed 
in   Fig. 6  . Online supplemental material is available at http://www.jcb
.org/cgi/content/full/jcb.200709030/DC1. 
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  In vitro cleavage assays 
  [ 
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